Objectives: To evaluate the impacts of health examinations (HE) and smoking on disease mortality risk in Japan.
Introduction
Similar to "Healthy People 2000" in the US and "Our Healthier Nation" in the UK, the Japanese Ministry of Health and Welfare has developed the national health campaign "Healthy Japan 21" (1) . It contains 48 targets that should be realized by 2010 for improvement of community health in Japan. Popularization of health examinations (HE) is presented as one of them. HE are regularly performed as a public health service in Japan. The aim is early detection and prompt treatment (a basic principle of preventing disease), which may reduce health risk for the subject and ultimately minimize the public burden of disease. However, few elements of HE have been proven to be effective for promoting health and preventing disease (2) . Moreover, direct epidemiological evidence about reduction in disease mortality by getting HE is insufficient.
Smoking cessation is also presented as one of the targets of "Healthy Japan 21". According to a national survey in 1999, 54.0% of men and 14.5% of women aged 20 years or older were current smokers in Japan (3). The smoking rate in Japan is near the peak level in western countries and ranks highly in the world. Independently of ethnicity, smoking is harmful to health (4) . If the smoking rates persist, mortality from smoking-related diseases will increases further in Japan as well as in western countries (5, 6, 7) . By using the large cohort database of a Japanese life insurance company, we evaluated the impacts of HE and smoking on disease mortality risk and demonstrated an association between HE and disease mortality in relation to smoking status.
Subjects and Methods
A longitudinal large cohort database was accumulated from a Japanese life insurance company. The cohort consisted of 720,611 eligible subjects (397,922 men; 322,689 women) aged 20 to 80 years, who had contracted life insurance between April 1, 1995 and March 31, 1998. They had completed on the contract day a structured questionnaire about HE over the past 2 years and their smoking status over the past year. Table 1 shows the baseline characteristics of the study subjects. At baseline, 79% of men and 70% of women were below age 40 years; 68% of men were smokers, whereas 74% of women were non-smokers; 83% of men and 79% of women were HEees (i.e. those who had got HE within the past 2 years).
Information on vital status and cause of death (disease, accident, suicide or others) was collected through the insurance payment records. We focused on disease death (death caused by any disease) and followed up the subjects to observe the occurrence of disease death until September 30, 1999. Mean±SD of the follow-up duration was 32.7±28.0 months. During the follow-up, 292,093 subjects (40.5%) had withdrawn the contracts. We considered them as censored cases, which were included in the data analysis.
We paid attention to protection of anonymity and confidentiality of the available data.
Statistical analyses
The statistical analyses were performed with the Statistical Analysis Systems (SAS, version 6.12). Mortality rate was estimated as the number of deaths per 100,000 person-months. Age-adjusted relative risks (RRs) and their corresponding 95% confidence intervals (CIs) were calculated from Cox's proportional hazard model (8) .
Results
There were 829 disease deaths (508 men; 321 women), which accounted for 74% of the total deaths. Disease mortality rates (per 100,000 person-months) were 3.79 among men and 3.16 among women ( Table 2, 3) .
After adjusting for age, disease mortality in smokers was significantly higher than that in non-smokers. Compared with nonsmokers, smokers had a 1.5-fold higher risk among men (RR 1.51, 95% CI: 1.25-1.81, Table 2 ), and also among women (RR 1.54, 95%CI: 1.12-2.11, Table 3 ). Meanwhile, disease mortality in HEees was significantly lower than that in non-HEees. Compared with non-HEees, HEees had a 0.7-fold lower risk among men (RR 0.70, 95% CI: 0.56-0.88, Table 2 ), and also among women (RR 0.71, 95% CI: 0.54-0.92, Table 3 ).
The magnitude of the impact of HE on disease mortality risk varied according to smoking status (Table 4) . Non-smokers showed a significantly lower risk associated with HE (men, RR 0.84, 95% CI: 0.35-0.67; women, RR 0.71, 95% CI: 0.53-0.95), whereas smokers did not (men, RR 0.93, 95% CI: 0.68-1.28; 
Discussion
This study was based on a large cohort database of HE, smoking and disease mortality in Japan. We demonstrated an association between HE and disease mortality in relation to smoking status, which might provide valuable evidence about reducing disease mortality in Japan by getting HE.
Disease mortality risk was significantly lower in HEees (i.e. those who had got HE within the past 2 years). As one possible reason, the HEees might have received counseling on medical treatment after the HE. Also, the HEees might be habitually careful about their health. The lower disease mortality risk in HEees seems to suggest both a preventive effect of HE and a good underlying well awareness of health.
In contrast to non-smokers, smokers showed no significantly lower disease mortality risk associated with HE. As one possible reason, excess risk associated with smoking might exceed the preventive effects of HE. Also, counseling on medical treatment after the HE might have limited effects on improvement of smokers' health. In spite of the excess risk associated with smoking, smokers tend to underestimate their health risk (9) . Because of awareness of health among smokers, it might be difficult to give them appropriate medical treatment and improve their lifestyles. Moreover, there are various potential complicating factors in the higher disease mortality risk in smokers (e.g. alcohol intake (5, 10, 11) , diet (10, 11, 12) , personality (9, 13, 14) and other cardiovascular risk factors (15, 16, 17, 18) ); smokers might have unhealthier lifestyles, besides smoking, than non-smokers. For smokers' health, it is important to promote awareness of health as well as encouraging them to quit smoking.
Due to the use of the database of a life insurance company, this study had the following potential limitations. First, the subjects were selected from life-insured persons. Since 75.2% of Japanese men and women aged 20 years or older had contracted life insurance (19) , the sampling bias of this study would seem to have a minor effect on our findings. However, the proportion of smokers was higher than that shown in the national survey (3) (men, 67.9% vs. 54.0%; women, 25.6% vs. 14.5%); the proportion of HEees (80.9%) was higher than that for the community populations (40.4%) (3) and lower than that for the worksite populations (85.1%) (20) . Second, the subjects were followed up for less than 4.5 years. The sample size of this study seems large enough to cancel out the effect of the short follow-up duration. We expect that other long cohort studies may confirm our findings. Finally, 40.5% of the subjects did not complete the follow-up. It is a wellknown fact that large number of censored cases undermines the credibility of the risk estimation by Cox's proportional hazard model. However, we found that the survival rates calculated from Cox's proportional hazard model were almost similar to those obtained in Kaplan-Mayer analysis. Unfortunately, we had no indepth information on the disease death (name or classification of the disease) and HE (contents of the HE). Further studies, taking into account these factors, may be required to gain a better understanding of the impacts of health examinations and smoking on disease mortality risk.
In conclusion, our results suggest that HE may allow an appreciable reduction in disease mortality; however, the reduction effect may be limited to non-smokers. Smoking cessation may be essential to improve the preventive effects of HE in Japan.
